Further Information
p52, p105, H2TF1, LYT10, CVID10, LYT-10, NF-kB2, EIF4F, EIF4G, EIF4GI, DNA-binding factor KBF2, Lymphocyte translocation chromosome 10, Lyt10, NFKB2
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200
NFKB has been detected in numerous cell types that express cytokines, chemokines, growth factors, cell adhesion molecules, and some acute phase proteins in health and in various disease states. NFKB is activated by a wide variety of stimuli such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. Inappropriate activation of NF-κ-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and AIDS. In contrast, complete and persistent inhibition of NF-κ-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth.
- Qu Z, et al. (2004) J Biol Chem. 279 (43): 44563-44572. Xiao G, et al. (2001) Mol Cell. 7 (2): 401-409. Baeuerle P A, et al. (1994) Annu Rev Immunol. 12:141-179. Baeuerle P A, et al. (1996) Cell 87:13-20. Haskill S, et al. (1991) Cell 65:1281-1289.
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
1 mg/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
NFkB-p100/p52 (Ab-866) antibody was raised against a peptide sequence around aa.864~868 (E-D-S-A-Y) derived from Human NFκB-p100/p52.
4791
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
NFKB2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
120 kDa
NP_001070961.1
117320540
Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Apoptosis,Cancer
This antibody detects endogenous level of total NFκB-p100/p52 protein.
Q00653